Transcribed
Metastatic Melanoma Clinical Trials
To unlock Download a Free Report Sample Click here Top Region North America North America Europe Middle East & Africa Asia - Pacific South & Central America GlobalData . To unlock Download a Free Report Sample Click here Top Region North America North America Europe Middle East & Africa Asia - Pacific South & Central America GlobalData .
Metastatic Melanoma Clinical Trials
shared by mailtotheowest on Nov 22
0
views
0
faves
0
comments
OpdualagTM is a first-in-class, fixed-dose dual immunotherapy combination of relatlimab and nivolumab that has been authorized for the treatment of unresectable or metastatic melanoma.
Opdualag is a s...
ingle-dose vial of a clear to opalescent, colorless to slightly yellow injectable solution comprising 240mg nivolumab and 80mg relatlimab per 20mL developed by Bristol-Myers Squibb (BMS) (12mg and 4mg per mL).
Publisher
Theo WestSource
https://glob...-analysis/Category
BusinessGet a Quote